Structure (Spl Image1 Structure)
Irbesartan Tablet
Product Images NDC 71205-082
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 71205-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Spl Image2 Figure1)
Figure 2 (Spl Image3 Figure2)
Figure 3 (Spl Image4 Figure3)
This appears to be a table displaying the results of a study comparing the effectiveness of two medications (besartan and amlodpine) against a placebo in treating an event in rats. The table includes the risk ratios (RR) and p-values for each comparison, as well as a graph showing the percentage of follow-up time in months.*
71205-082-30 (Spl Image6 Irbesartan 150mg)
This is a package of Irbesartan 150mg medication with 30 tablets, manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd. in China. Each tablet is white to off-white biconvex oval-shaped, debossed with 'HH' on one side and ‘330’ on the other. The medication should be stored at 20°-25°C (68°-77°F) and kept out of reach of children. The lot number is 00000 and the expiration date is 00/00/00. The medication is for RX only and the product ID is Q1008230. The package was distributed by Proficient Rx LP in Thousand Oaks, CA 91320.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
